Human Recombinant Insulin Market Is Estimated To Witness High Growth Owing To Increasing Diabetes Prevalence
The Human Recombinant Insulin Market is estimated to be valued at Us$ 41602.7 Mn in 2023 and is expected to exhibit a CAGR Of 11.% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Human recombinant insulin is a biosynthetic human insulin protein produced by recombinant DNA technology, which is used for the treatment of...
0 Yorumlar 0 hisse senetleri 1449 Views 0 önizleme
Sponsorluk